...
search icon
hyft-img

ImmunoPrecise Antibodies Ltd., Common Stock

HYFT

NAQ

$2.015

+$0.29

(16.76%)

1D

Analyst Forecast

Price Chart

Key Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$79.85M
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
0
Volume info-icon
This is the total number of shares traded during the most recent trading day.
2.36M
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
0
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$0.27 L
$3.25 H
$2.015

About ImmunoPrecise Antibodies Ltd., Common Stock

MindWalk Holdings Corp. operates as an AI-driven biotherapeutic research, technology, and scientifically robust life science company. It discovers and develops customized and novel antibodies by generating proprietary and patented processes, procedures, and innovative approaches to antibody discovery, development, and production. The company was formerly known as ImmunoPrecise Antibodies Ltd. and changed its name to MindWalk Holdings Corp. in September 2025. The company was incorporated in 1983 and is headquartered in Austin, Texas. more

Returns

Data is not properly formatted.

Financials

Apr '22Apr '23Apr '24Apr '25
Total Revenue19.36M20.66M24.52M24.52M[{"date":"2022-04-30","value":78.97,"profit":true},{"date":"2023-04-30","value":84.28,"profit":true},{"date":"2024-04-30","value":99.99,"profit":true},{"date":"2025-04-30","value":100,"profit":true}]
Cost of Revenue8.38M9.10M12.46M10.97M[{"date":"2022-04-30","value":67.24,"profit":true},{"date":"2023-04-30","value":73.02,"profit":true},{"date":"2024-04-30","value":100,"profit":true},{"date":"2025-04-30","value":88.02,"profit":true}]
Gross Profit10.98M11.56M12.05M13.55M[{"date":"2022-04-30","value":81.07,"profit":true},{"date":"2023-04-30","value":85.35,"profit":true},{"date":"2024-04-30","value":88.97,"profit":true},{"date":"2025-04-30","value":100,"profit":true}]
Gross Margin56.72%55.95%49.16%55.25%[{"date":"2022-04-30","value":100,"profit":true},{"date":"2023-04-30","value":98.65,"profit":true},{"date":"2024-04-30","value":86.67,"profit":true},{"date":"2025-04-30","value":97.42,"profit":true}]
Operating Expenses36.04M46.28M38.28M36.72M[{"date":"2022-04-30","value":77.87,"profit":true},{"date":"2023-04-30","value":100,"profit":true},{"date":"2024-04-30","value":82.72,"profit":true},{"date":"2025-04-30","value":79.34,"profit":true}]
Operating Income(16.67M)(25.61M)(13.76M)(12.20M)[{"date":"2022-04-30","value":-1667300000,"profit":false},{"date":"2023-04-30","value":-2561100000,"profit":false},{"date":"2024-04-30","value":-1376200000,"profit":false},{"date":"2025-04-30","value":-1219600000,"profit":false}]
Total Non-Operating Income/Expense825.00K(2.14M)(14.94M)(22.07M)[{"date":"2022-04-30","value":100,"profit":true},{"date":"2023-04-30","value":-259.52,"profit":false},{"date":"2024-04-30","value":-1811.03,"profit":false},{"date":"2025-04-30","value":-2675.27,"profit":false}]
Pre-Tax Income(15.85M)(27.75M)(28.70M)(34.27M)[{"date":"2022-04-30","value":-1584800000,"profit":false},{"date":"2023-04-30","value":-2775200000,"profit":false},{"date":"2024-04-30","value":-2870300000,"profit":false},{"date":"2025-04-30","value":-3426700000,"profit":false}]
Income Taxes----[{"date":"2022-04-30","value":"-","profit":true},{"date":"2023-04-30","value":"-","profit":true},{"date":"2024-04-30","value":"-","profit":true},{"date":"2025-04-30","value":"-","profit":true}]
Income After Taxes----[{"date":"2022-04-30","value":"-","profit":true},{"date":"2023-04-30","value":"-","profit":true},{"date":"2024-04-30","value":"-","profit":true},{"date":"2025-04-30","value":"-","profit":true}]
Income From Continuous Operations(16.71M)(26.56M)(26.11M)(30.23M)[{"date":"2022-04-30","value":-1670900000,"profit":false},{"date":"2023-04-30","value":-2656000000,"profit":false},{"date":"2024-04-30","value":-2611500000,"profit":false},{"date":"2025-04-30","value":-3023400000,"profit":false}]
Income From Discontinued Operations----[{"date":"2022-04-30","value":"-","profit":true},{"date":"2023-04-30","value":"-","profit":true},{"date":"2024-04-30","value":"-","profit":true},{"date":"2025-04-30","value":"-","profit":true}]
Net Income(16.71M)(26.56M)(26.11M)(30.23M)[{"date":"2022-04-30","value":-1670900000,"profit":false},{"date":"2023-04-30","value":-2656000000,"profit":false},{"date":"2024-04-30","value":-2611500000,"profit":false},{"date":"2025-04-30","value":-3023400000,"profit":false}]
EPS (Diluted)(0.67)(0.81)(0.76)(0.67)[{"date":"2022-04-30","value":-67.19,"profit":false},{"date":"2023-04-30","value":-80.76,"profit":false},{"date":"2024-04-30","value":-76.14,"profit":false},{"date":"2025-04-30","value":-66.82,"profit":false}]

Ratios

Liquidity

These ratios help you determine the liquidity of the company. Higher is better.

HYFT
Current Ratio 2.08
Quick Ratio 1.85

Asset Efficiency

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

HYFT
ROA (LTM) 0.00%
ROE (LTM) 0.00%

Liabilities

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

HYFT
Debt Ratio Lower is generally better. Negative is bad. 0.47
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. 0.53

Valuation

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

HYFT
Trailing PE NM
Forward PE NM
P/S (TTM) 0.00
P/B 0.00
EV/R 0.00
EV/Ebitda NM

FAQs

What is ImmunoPrecise Antibodies Ltd. share price today?

ImmunoPrecise Antibodies Ltd. (HYFT) share price today is $2.015

Can Indians buy ImmunoPrecise Antibodies Ltd. shares?

Yes, Indians can buy shares of ImmunoPrecise Antibodies Ltd. (HYFT) on Vested. To buy ImmunoPrecise Antibodies Ltd. from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in HYFT stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of ImmunoPrecise Antibodies Ltd. be purchased?

Yes, you can purchase fractional shares of ImmunoPrecise Antibodies Ltd. (HYFT) via the Vested app. You can start investing in ImmunoPrecise Antibodies Ltd. (HYFT) with a minimum investment of $1.

How to invest in ImmunoPrecise Antibodies Ltd. shares from India?

You can invest in shares of ImmunoPrecise Antibodies Ltd. (HYFT) via Vested in three simple steps:

  • Click on Sign Up or Invest in HYFT stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in ImmunoPrecise Antibodies Ltd. shares
What is ImmunoPrecise Antibodies Ltd. 52-week high and low stock price?

The 52-week high price of ImmunoPrecise Antibodies Ltd. (HYFT) is $3.25. The 52-week low price of ImmunoPrecise Antibodies Ltd. (HYFT) is $0.27.

What is ImmunoPrecise Antibodies Ltd. price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of ImmunoPrecise Antibodies Ltd. (HYFT) is 0.00

What is the Market Cap of ImmunoPrecise Antibodies Ltd.?

The market capitalization of ImmunoPrecise Antibodies Ltd. (HYFT) is $79.85M

What is ImmunoPrecise Antibodies Ltd.’s stock symbol?

The stock symbol (or ticker) of ImmunoPrecise Antibodies Ltd. is HYFT

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top